爱朋医疗
(300753)
| 流通市值：25.40亿 | | | 总市值：36.43亿 |
| 流通股本：8790.58万 | | | 总股本：1.26亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 159,166,688.58 | 64,821,886.38 | 403,802,245.57 | 274,753,514.1 |
| 营业收入 | 159,166,688.58 | 64,821,886.38 | 403,802,245.57 | 274,753,514.1 |
| 二、营业总成本 | 183,044,550.6 | 86,653,651.22 | 398,548,720.03 | 271,029,178.03 |
| 营业成本 | 58,538,084.09 | 24,692,282.96 | 127,529,963.71 | 85,112,978.52 |
| 税金及附加 | 2,029,365.16 | 998,934.32 | 4,989,594.26 | 3,472,498.02 |
| 销售费用 | 69,241,795.79 | 35,058,141.07 | 154,030,675.93 | 100,705,131.68 |
| 管理费用 | 33,507,563.5 | 16,357,440.28 | 77,580,543.56 | 57,431,028.93 |
| 研发费用 | 18,753,949.82 | 8,829,562.22 | 33,277,595.24 | 23,409,768.84 |
| 财务费用 | 973,792.24 | 717,290.37 | 1,140,347.33 | 897,772.04 |
| 其中:利息费用 | 1,570,417.24 | 776,088.59 | 3,066,381.22 | 2,269,106.8 |
| 其中:利息收入 | 628,478.48 | 75,178.74 | 1,982,976.77 | 1,419,121.75 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 1,010,455.62 | 683,600.98 | -1,384,285.52 | -598,285.1 |
| 资产处置收益 | 63,139.44 | - | 3,589,227.98 | 3,643,568.78 |
| 资产减值损失(新) | -274,673.04 | -273,816.71 | -585,189.23 | -113,597.17 |
| 信用减值损失(新) | -7,044,332.89 | -1,473,721.39 | -5,830,218.61 | -3,110,332.15 |
| 其他收益 | 4,325,562.46 | 2,793,362.44 | 22,443,958.12 | 9,428,807.57 |
| 四、营业利润 | -25,797,710.43 | -20,102,339.52 | 23,487,018.28 | 12,974,498 |
| 加:营业外收入 | 4,239.28 | 3,601.15 | 345.65 | 941.14 |
| 减:营业外支出 | 536,116.65 | 455,460.13 | 2,320,325.06 | 2,476,736.18 |
| 五、利润总额 | -26,329,587.8 | -20,554,198.5 | 21,167,038.87 | 10,498,702.96 |
| 减:所得税费用 | -6,476,275.36 | -1,983,769.02 | 10,272,207.14 | 6,626,807.72 |
| 六、净利润 | -19,853,312.44 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -19,853,312.44 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -19,379,092.01 | -17,649,164.17 | 10,800,733.83 | 3,807,308.09 |
| 少数股东损益 | -474,220.43 | -921,265.31 | 94,097.9 | 64,587.15 |
| 扣除非经常损益后的净利润 | -20,141,917.33 | -17,949,782.89 | 6,231,609.6 | 872,102.36 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.15 | -0.14 | 0.09 | 0.03 |
| (二)稀释每股收益 | -0.15 | -0.14 | 0.09 | 0.03 |
| 九、综合收益总额 | -19,853,312.44 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 |
| 归属于母公司股东的综合收益总额 | -19,379,092.01 | -17,649,164.17 | 10,800,733.83 | 3,807,308.09 |
| 归属于少数股东的综合收益总额 | -474,220.43 | -921,265.31 | 94,097.9 | 64,587.15 |
| 公告日期 | 2025-08-28 | 2025-04-29 | 2025-04-19 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |